Inactive Instrument

Mymetics Corp Share Price OTC Bulletin Board

Biotechnology & Medical Research

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

20/23/20	Mymetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
18/23/18	Mymetics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Mymetics Corporation is a vaccine company. The Company is focused on developing vaccines for infectious diseases. The Company has over five vaccine candidates in its pipeline: human immunodeficiency virus type 1 (HIV-1)/acquired immune deficiency syndrome (AIDS), intra nasal Influenza, Malaria, Herpes Simplex Virus (HSV) and the Respiratory Syncitial Virus (RSV) vaccine. Its technology utilizes virosomes, lipid-based carriers containing functional fusion viral proteins and natural membrane proteins, in combination with rationally designed antigens. Its prophylactic HIV-1 vaccine candidate is constituted of virosomes linked to conserved antigens derived from the HIV-1 glycoprotein 41 (gp41) proteins from the clade B. The RSV vaccine consists of the reconstituted membrane of RSV containing the native viral proteins. The HSV vaccine candidate consists of the reconstituted membrane of HSV-1 or HSV-2. The intranasal influenza vaccine includes the reconstituted membrane of influenza virus.

Employees

Sector

Biotechnology & Medical Research

More about the company

All transcripts on over 9000 companies, on the day they post their earnings!

Unlock them now!

Market Cap	4L 4L 4L 3L 6L 4.18Cr 6L 41.58L 16.32L 2.09Cr 16.48L 16.12L 6.92Cr	P/E 2021	-1.86x	P/E 2022	-1.77x
Enterprise Value	7.21Cr 6.24Cr 5.83Cr 5.34Cr 10Cr 686.4Cr 10Cr 68Cr 27Cr 344.04Cr 27Cr 26Cr 1.14TCr	EV / Sales 2021	177x	EV / Sales 2022	78x
Free-Float	99.88%	Yield 2021 *	-	Yield 2022	-

20/23/20	Mymetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
18/23/18	Mymetics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI
16/23/16	Mymetics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023	CI
11/23/11	Mymetics Corporation Reports Earnings Results for the Full Year Ended December 31, 2022	CI
11/23/11	Mymetics Corporation Auditor Raises 'Going Concern' Doubt	CI
17/23/17	Mymetics Corporation Appoints Marcel B. Rüegg to the Board	CI
29/22/29	Mymetics Corporation Announces Resignation of Ernest M. Stern as A Member of the Board of Directors	CI
14/22/14	Mymetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
11/22/11	Mymetics Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI
13/22/13	Mymetics Corporation Reports Earnings Results for the First Quarter Ended March 31, 2022	CI
01/22/01	Mymetics Corporation Reports Earnings Results for the Full Year Ended December 31, 2021	CI
31/22/31	Mymetics Corporation Auditor Raises 'Going Concern' Doubt	CI
12/21/12	Mymetics Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	CI

11/23/11	MYMETICS CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ
27/23/27	MYMETICS CORP : Other Events (form 8-K)	AQ
09/23/09	MYMETICS CORP : Other Events (form 8-K)	AQ
17/23/17	MYMETICS CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
29/22/29	MYMETICS CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
WUXI APPTEC CO., LTD.	+8.49%	+20.55%	+70.77%	+110.32%	6.81TCr
ARGENX SE	+1.25%	+2.44%	+34.27%	+70.43%	5.52TCr
INSMED INCORPORATED	-1.09%	+32.96%	+19.67%	+494.56%	2.86TCr
WUXI BIOLOGICS (CAYMAN) INC.	+10.83%	+18.38%	+56.20%	+6.03%	2.4TCr
BIONTECH SE	+2.72%	+3.41%	-16.11%	-7.96%	2.35TCr
GENMAB A/S	+6.50%	+7.56%	+44.65%	-21.73%	1.84TCr
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	+6.20%	+11.51%	+33.87%	+693.38%	1.64TCr
PHARMAESSENTIA CORPORATION	-3.88%	+16.98%	+199.30%	+359.77%	1.58TCr
EXELIXIS, INC.	+3.58%	+1.96%	+43.35%	+163.76%	1.34TCr
Average	+3.84%	+11.68%	+54.00%	+207.62%	2.93TCr
Weighted average by Cap.	+4.36%	+13.10%	+50.69%	+168.47%

	2021	2022
Net sales	4L 4L 3L 3L 6L 4.09Cr 6L 40.75L 16L 2.05Cr 16.15L 15.79L 6.78Cr	10.28L 9L 8L 8L 14.33L 9.78Cr 14.56L 97.43L 38.24L 4.9Cr 38.6L 37.76L 16Cr
Net income	-47.3L -40.91L -38.21L -35.05L -65.92L -45Cr -66.97L -4.48Cr -1.76Cr -23Cr -1.78Cr -1.74Cr -75Cr	-48.05L -41.56L -38.81L -35.61L -66.97L -46Cr -68.03L -4.55Cr -1.79Cr -23Cr -1.8Cr -1.76Cr -76Cr
Net Debt	6.71Cr 5.8Cr 5.42Cr 4.97Cr 9.35Cr 638.6Cr 9.5Cr 64Cr 25Cr 320.08Cr 25Cr 25Cr 1.06TCr	7.17Cr 6.2Cr 5.79Cr 5.31Cr 9.99Cr 682.23Cr 10Cr 68Cr 27Cr 341.95Cr 27Cr 26Cr 1.13TCr

Mymetics Corp Share Price OTC Bulletin Board

Stocks

Biotechnology & Medical Research

Valuation: Mymetics Corp

Latest news : Mymetics Corp

Press Releases: Mymetics Corp

Managers and Directors: Mymetics Corp

Bio Therapeutic Drugs

Financials

Company Profile